Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 23    symbols : SRNE    save search
Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Published: 2021-07-23 (Crawled : 16:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 0 twitter stocktwits trandingview |
Health Technology
 | | O: -0.34% H: 0.0% C: -5.13%
treatment lung cancer cancer antibody license
Gainers vs Losers
58% 42%

Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M twitter stocktwits trandingview |
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M twitter stocktwits trandingview |
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K twitter stocktwits trandingview |

EGOX | $0.036 12.15% 31.56% 32M twitter stocktwits trandingview |

TIRX | $0.8 65.02% 25.95% 410K twitter stocktwits trandingview |

VTNR 4 | $1.31 33.78% 25.82% 220K twitter stocktwits trandingview |
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M twitter stocktwits trandingview |

TPET | $0.3279 -3.56% 23.57% 11M twitter stocktwits trandingview |
n/a
HOLO | $2.95 31.7% 22.49% 37M twitter stocktwits trandingview |

MTNB | $0.19 -1.04% 14.58% 950K twitter stocktwits trandingview |
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.